Annotation (Toggle Detail/Summary View) | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Gene-Chemical Interaction Annotations
Gene-Chemical Interaction AnnotationsTerm | Qualifier | Evidence | With | Reference | Notes | Source | Original Reference(s) | 17alpha-ethynylestradiol | affects expression | ISO | RGD:1332211 | 6480464 | Ethinyl Estradiol affects the expression of ABL1 mRNA | CTD | PMID:17555576 | 17alpha-ethynylestradiol | multiple interactions | ISO | RGD:1332211 | 6480464 | [Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of ABL1 mRNA | CTD | PMID:17942748 | 17alpha-ethynylestradiol | increases expression | ISO | RGD:1332211 | 6480464 | Ethinyl Estradiol results in increased expression of ABL1 mRNA | CTD | PMID:17942748 | 2,3,7,8-tetrachlorodibenzodioxine | multiple interactions | ISO | RGD:1332211 | 6480464 | [Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of ABL1 mRNA | CTD | PMID:17942748 | 2,3,7,8-tetrachlorodibenzodioxine | increases expression | ISO | RGD:1332211 | 6480464 | Tetrachlorodibenzodioxin results in increased expression of ABL1 mRNA | CTD | PMID:17942748 | 2-methylcholine | affects expression | EXP | | 6480464 | beta-methylcholine affects the expression of ABL1 mRNA | CTD | PMID:21179406 | 4-hydroperoxycyclophosphamide | increases expression | ISO | RGD:1332211 | 6480464 | perfosfamide results in increased expression of ABL1 mRNA | CTD | PMID:19429390 | 4-nitroquinoline N-oxide | increases expression | ISO | RGD:1332211 | 6480464 | 4-Nitroquinoline-1-oxide results in increased expression of ABL1 mRNA | CTD | PMID:22561872 | 4-nitroquinoline N-oxide | decreases expression | ISO | RGD:1332211 | 6480464 | 4-Nitroquinoline-1-oxide results in decreased expression of ABL1 mRNA | CTD | PMID:22561872 | acetaldehyde | multiple interactions | EXP | | 6480464 | ABL1 protein promotes the reaction [Acetaldehyde results in increased phosphorylation of and results in decreased activity of PPARG protein]; more ... | CTD | PMID:17030193 | acetaldehyde | increases activity | EXP | | 6480464 | Acetaldehyde results in increased activity of ABL1 protein | CTD | PMID:17030193 | all-trans-retinoic acid | increases expression | ISO | RGD:1332211 | 6480464 | Tretinoin results in increased expression of ABL1 mRNA | CTD | PMID:16788091 | all-trans-retinoic acid | multiple interactions | EXP | | 6480464 | [Tretinoin co-treated with arsenic trioxide] results in increased expression of ABL1 mRNA | CTD | PMID:15894607 | amiodarone | increases expression | EXP | | 6480464 | Amiodarone results in increased expression of ABL1 mRNA | CTD | PMID:19774075 | ammonium chloride | increases expression | ISO | RGD:1584969 | 6480464 | Ammonium Chloride results in increased expression of ABL1 protein | CTD | PMID:16483693 | ATP | multiple interactions | EXP | | 6480464 | [ABL1 protein mutant form co-treated with Adenosine Triphosphate] results in increased phosphorylation of CRKL protein; more ... | CTD | PMID:19366808 | atropine | multiple interactions | EXP | | 6480464 | [Parathion co-treated with Atropine] results in increased expression of ABL1 mRNA | CTD | PMID:17390078 | benzo[a]pyrene | multiple interactions | ISO | RGD:1332211 | 6480464 | [Benzo(a)pyrene co-treated with XPA gene mutant form co-treated with TRP53 gene mutant form] results in decreased expression of ABL1 mRNA | CTD | PMID:21715664 | C60 fullerene | increases expression | ISO | RGD:1584969 | 6480464 | fullerene C60 results in increased expression of ABL1 mRNA | CTD | PMID:19167457 | cadmium dichloride | multiple interactions | ISO | RGD:1332211 | 6480464 | [Methylnitronitrosoguanidine co-treated with Cadmium Chloride] results in increased expression of ABL1 mRNA | CTD | PMID:19840844 | calcitriol | increases expression | EXP | | 6480464 | Calcitriol results in increased expression of ABL1 mRNA | CTD | PMID:21592394 | calcitriol | multiple interactions | EXP | | 6480464 | [Testosterone co-treated with Calcitriol] results in increased expression of ABL1 mRNA | CTD | PMID:21592394 | capsaicin | increases expression | EXP | | 6480464 | Capsaicin results in increased expression of ABL1 mRNA | CTD | PMID:19502594 | cisplatin | multiple interactions | EXP | | 6480464 | [Cisplatin co-treated with 2,5,7,8-tetramethyl-2R-(4R,8R,12-trimethyltridecyl)chroman-6-yloxy acetic acid] results in increased phosphorylation of ABL1 protein; more ... | CTD | PMID:21214929 | cisplatin | increases expression | ISO | RGD:1584969 | 6480464 | Cisplatin results in increased expression of ABL1 protein | CTD | PMID:22023808 | cisplatin | multiple interactions | EXP | | 6480464 | [Cisplatin co-treated with LBH589] affects the expression of ABL1 mRNA; more ... | CTD | PMID:21791302 | cisplatin | increases response to substance | EXP | | 6480464 | ABL1 protein results in increased susceptibility to Cisplatin | CTD | PMID:21324906 | cocaine | affects expression | ISO | RGD:1332211 | 6480464 | Cocaine affects the expression of ABL1 mRNA | CTD | PMID:15681117 | copper atom | multiple interactions | EXP | | 6480464 | [Thiosemicarbazones binds to Copper] which results in increased expression of ABL1 protein | CTD | PMID:20931265 | copper(0) | multiple interactions | EXP | | 6480464 | [Thiosemicarbazones binds to Copper] which results in increased expression of ABL1 protein | CTD | PMID:20931265 | cytochalasin D | multiple interactions | ISO | RGD:1332211 | 6480464 | EGF protein inhibits the reaction [Cytochalasin D results in increased phosphorylation of ABL1 protein] | CTD | PMID:21900236 | cytochalasin D | increases phosphorylation | ISO | RGD:1332211 | 6480464 | Cytochalasin D results in increased phosphorylation of ABL1 protein | CTD | PMID:21900236 | dasatinib (anhydrous) | decreases activity | EXP | | 6480464 | dasatinib results in decreased activity of ABL1 protein mutant form | CTD | PMID:19100678 | dasatinib (anhydrous) | decreases phosphorylation | EXP | | 6480464 | dasatinib results in decreased phosphorylation of ABL1 protein mutant form | CTD | PMID:17020995 PMID:19878872 | dasatinib (anhydrous) | multiple interactions | EXP | | 6480464 | dasatinib inhibits the reaction [ABL1 protein mutant form results in increased phosphorylation of CRKL protein] | CTD | PMID:19100678 PMID:19878872 | dasatinib (anhydrous) | multiple interactions | EXP | | 6480464 | dasatinib inhibits the reaction [ABL1 protein results in increased phosphorylation of ABL1 protein] | CTD | PMID:19878872 | dasatinib (anhydrous) | affects binding | EXP | | 6480464 | dasatinib binds to ABL1 protein mutant form | CTD | PMID:18180381 PMID:17684099 | dasatinib (anhydrous) | affects binding | ISO | RGD:1332211 | 6480464 | dasatinib binds to ABL1 protein | CTD | PMID:17684099 | dasatinib (anhydrous) | decreases phosphorylation | EXP | | 6480464 | dasatinib results in decreased phosphorylation of ABL1 protein mutant form | CTD | PMID:17020995 | dasatinib (anhydrous) | multiple interactions | EXP | | 6480464 | [dasatinib co-treated with vorinostat] results in decreased phosphorylation of ABL1 protein mutant form; more ... | CTD | PMID:17020995 | dasatinib (anhydrous) | affects binding | EXP | | 6480464 | dasatinib binds to ABL1 protein; more ... | CTD | PMID:17684099 PMID:18180381 | daunorubicin | decreases response to substance | EXP | | 6480464 | ABL1 results in decreased susceptibility to Daunorubicin | CTD | PMID:12410571 | diarsenic trioxide | multiple interactions | EXP | | 6480464 | [arsenic trioxide co-treated with bortezomib] results in decreased expression of ABL1 protein | CTD | PMID:17495969 | diarsenic trioxide | decreases expression | EXP | | 6480464 | arsenic trioxide results in decreased expression of ABL1 protein | CTD | PMID:10648417 | diarsenic trioxide | affects response to substance | EXP | | 6480464 | ABL1 protein affects the susceptibility to arsenic trioxide | CTD | PMID:10648417 | diarsenic trioxide | multiple interactions | EXP | | 6480464 | [Tretinoin co-treated with arsenic trioxide] results in increased expression of ABL1 mRNA | CTD | PMID:15894607 | diarsenic trioxide | decreases expression | EXP | | 6480464 | arsenic trioxide results in decreased expression of ABL1 mRNA | CTD | PMID:20458559 | diarsenic trioxide | decreases expression | EXP | | 6480464 | arsenic trioxide results in decreased expression of ABL1 protein mutant form | CTD | PMID:14633726 | doxorubicin | multiple interactions | EXP | | 6480464 | [Doxorubicin co-treated with 2,5,7,8-tetramethyl-2R-(4R,8R,12-trimethyltridecyl)chroman-6-yloxy acetic acid] results in increased phosphorylation of ABL1 protein; more ... | CTD | PMID:21214929 | gallic acid | multiple interactions | EXP | | 6480464 | Gallic Acid results in decreased phosphorylation of [BCR protein mutant form binds to ABL1 protein mutant form]; more ... | CTD | PMID:22245431 | histamine | multiple interactions | EXP | | 6480464 | 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [[BCR protein mutant form binds to ABL1 protein mutant form] which results in increased chemical synthesis of Histamine]; more ... | CTD | PMID:16849647 | hydrogen peroxide | increases activity | EXP | | 6480464 | Hydrogen Peroxide results in increased activity of ABL1 protein | CTD | PMID:17030193 | hydrogen peroxide | affects expression | EXP | | 6480464 | Hydrogen Peroxide affects the expression of ABL1 protein | CTD | PMID:21179406 | hydrogen peroxide | multiple interactions | EXP | | 6480464 | imatinib inhibits the reaction [Hydrogen Peroxide results in increased activity of ABL1 protein] | CTD | PMID:17030193 | imatinib | multiple interactions | EXP | | 6480464 | imatinib results in decreased expression of [BCR protein mutant form binds to ABL1 protein mutant form] | CTD | PMID:22397755 | imatinib | multiple interactions | EXP | | 6480464 | imatinib inhibits the reaction [ABL1 protein results in increased phosphorylation of ABL1 protein]; more ... | CTD | PMID:19878872 | imatinib | decreases phosphorylation | EXP | | 6480464 | imatinib results in decreased phosphorylation of ABL1 protein mutant form | CTD | PMID:19366808 PMID:19878872 | imatinib | multiple interactions | EXP | | 6480464 | Gallic Acid promotes the reaction [imatinib results in decreased phosphorylation of [BCR protein mutant form binds to ABL1 protein mutant form]]; more ... | CTD | PMID:22245431 | imatinib | decreases expression | ISO | RGD:1332211 | 6480464 | imatinib results in decreased expression of ABL1 protein; more ... | CTD | PMID:16481037 | imatinib | decreases phosphorylation | ISO | RGD:1332211 | 6480464 | imatinib results in decreased phosphorylation of ABL1 protein | CTD | PMID:12032135 | imatinib | multiple interactions | EXP | | 6480464 | [vorinostat co-treated with imatinib] results in decreased expression of ABL1 protein mutant form; more ... | CTD | PMID:12446442 | imatinib | decreases phosphorylation | EXP | | 6480464 | imatinib results in decreased phosphorylation of ABL1 protein mutant form | CTD | PMID:19366808 | imatinib | decreases activity | EXP | | 6480464 | imatinib results in decreased activity of ABL1 protein mutant form | CTD | PMID:15329907 | imatinib | multiple interactions | EXP | | 6480464 | imatinib inhibits the reaction [[BCR protein mutant form binds to ABL1 protein mutant form] which results in increased expression of HDC mRNA]; more ... | CTD | PMID:16849647 | imatinib | multiple interactions | EXP | | 6480464 | imatinib inhibits the reaction [Acetaldehyde results in increased activity of ABL1 protein]; more ... | CTD | PMID:17030193 | imatinib | decreases response to substance | EXP | | 6480464 | ABL1 protein results in decreased susceptibility to imatinib | CTD | PMID:15039284 | imatinib | increases response to substance | EXP | | 6480464 | ABL1 mutant form results in increased susceptibility to imatinib | CTD | PMID:15107311 | LY294002 | multiple interactions | EXP | | 6480464 | 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [[BCR protein mutant form binds to ABL1 protein mutant form] which results in increased chemical synthesis of Histamine]; more ... | CTD | PMID:16849647 | mangiferin | decreases expression | EXP | | 6480464 | mangiferin results in decreased expression of ABL1 mRNA | CTD | PMID:15498116 | mercury atom | increases expression | EXP | | 6480464 | Mercury results in increased expression of ABL1 mRNA | CTD | PMID:19937285 | mercury(0) | increases expression | EXP | | 6480464 | Mercury results in increased expression of ABL1 mRNA | CTD | PMID:19937285 | methylmercury chloride | increases expression | ISO | RGD:1332211 | 6480464 | methylmercuric chloride results in increased expression of ABL1 mRNA | CTD | PMID:20061341 | N-acetyl-L-cysteine | multiple interactions | ISO | RGD:1332211 | 6480464 | Acetylcysteine inhibits the reaction [NSC 680410 results in decreased phosphorylation of ABL1 protein] | CTD | PMID:16481037 | N-methyl-N'-nitro-N-nitrosoguanidine | multiple interactions | ISO | RGD:1332211 | 6480464 | [Methylnitronitrosoguanidine co-treated with Okadaic Acid] results in increased expression of ABL1 mRNA; more ... | CTD | PMID:19840844 | okadaic acid | multiple interactions | ISO | RGD:1332211 | 6480464 | [Methylnitronitrosoguanidine co-treated with Okadaic Acid] results in increased expression of ABL1 mRNA | CTD | PMID:19840844 | paracetamol | affects expression | ISO | RGD:1332211 | 6480464 | Acetaminophen affects the expression of ABL1 mRNA | CTD | PMID:17562736 | paraquat | increases expression | EXP | | 6480464 | Paraquat results in increased expression of ABL1 mRNA | CTD | PMID:18836921 | parathion | multiple interactions | EXP | | 6480464 | [Parathion co-treated with Atropine] results in increased expression of ABL1 mRNA | CTD | PMID:17390078 | parathion | increases expression | EXP | | 6480464 | Parathion results in increased expression of ABL1 mRNA | CTD | PMID:17390078 | phenobarbital | decreases methylation | ISO | RGD:1332211 | 6480464 | Phenobarbital results in decreased methylation of ABL1 gene | CTD | PMID:19233941 | phenobarbital | increases expression | ISO | RGD:1332211 | 6480464 | Phenobarbital results in increased expression of ABL1 mRNA | CTD | PMID:19482888 | phenobarbital | decreases methylation | ISO | RGD:1332211 | 6480464 | Phenobarbital results in decreased methylation of ABL1 promoter | CTD | PMID:19482888 | phenylephrine | multiple interactions | ISO | RGD:1584969 | 6480464 | ABL1 protein affects the reaction [Phenylephrine promotes the reaction [BCAR1 protein binds to CRK protein]]; more ... | CTD | PMID:17615370 | phenylephrine | increases phosphorylation | ISO | RGD:1584969 | 6480464 | Phenylephrine results in increased phosphorylation of ABL1 protein | CTD | PMID:17615370 | phenylephrine | affects response to substance | ISO | RGD:1584969 | 6480464 | ABL1 protein affects the susceptibility to Phenylephrine | CTD | PMID:17615370 | phorbol 13-acetate 12-myristate | multiple interactions | ISO | RGD:1332211 | 6480464 | [Methylnitronitrosoguanidine co-treated with Tetradecanoylphorbol Acetate] results in increased expression of ABL1 mRNA | CTD | PMID:19840844 | potassium chloride | multiple interactions | ISO | RGD:1584969 | 6480464 | ABL1 protein affects the reaction [Potassium Chloride results in increased phosphorylation of BCAR1 protein] | CTD | PMID:17615370 | potassium chloride | increases phosphorylation | ISO | RGD:1584969 | 6480464 | Potassium Chloride results in increased phosphorylation of ABL1 protein | CTD | PMID:17615370 | potassium chloride | affects response to substance | ISO | RGD:1584969 | 6480464 | ABL1 protein affects the susceptibility to Potassium Chloride | CTD | PMID:17615370 | resveratrol | multiple interactions | EXP | | 6480464 | resveratrol results in decreased expression of [BCR protein mutant form binds to ABL1 protein mutant form]; more ... | CTD | PMID:22397755 | tamoxifen | affects expression | ISO | RGD:1332211 | 6480464 | Tamoxifen affects the expression of ABL1 mRNA | CTD | PMID:17555576 | tamoxifen | decreases response to substance | EXP | | 6480464 | ABL1 protein results in decreased susceptibility to Tamoxifen | CTD | PMID:20234815 | testosterone | increases expression | EXP | | 6480464 | Testosterone results in increased expression of ABL1 mRNA | CTD | PMID:21592394 | testosterone | multiple interactions | EXP | | 6480464 | [Testosterone co-treated with Calcitriol] results in increased expression of ABL1 mRNA | CTD | PMID:21592394 | tetrachloromethane | increases phosphorylation | EXP | | 6480464 | Carbon Tetrachloride results in increased phosphorylation of ABL1 protein | CTD | PMID:17030193 | tetrachloromethane | multiple interactions | EXP | | 6480464 | imatinib inhibits the reaction [Carbon Tetrachloride results in increased phosphorylation of ABL1 protein] | CTD | PMID:17030193 | trans-resveratrol | multiple interactions | EXP | | 6480464 | resveratrol results in decreased expression of [BCR protein mutant form binds to ABL1 protein mutant form]; more ... | CTD | PMID:22397755 | trichostatin A | decreases expression | EXP | | 6480464 | trichostatin A results in decreased expression of ABL1 mRNA | CTD | PMID:19606018 | valproic acid | increases expression | ISO | RGD:1332211 | 6480464 | Valproic Acid results in increased expression of ABL1 mRNA | CTD | PMID:21427059 | vanadium atom | increases expression | EXP | | 6480464 | Vanadium results in increased expression of ABL1 mRNA | CTD | PMID:19000753 | vanadium(0) | increases expression | EXP | | 6480464 | Vanadium results in increased expression of ABL1 mRNA | CTD | PMID:19000753 | zinc atom | affects expression | EXP | | 6480464 | Zinc affects the expression of ABL1 protein | CTD | PMID:16636310 | zinc(0) | affects expression | EXP | | 6480464 | Zinc affects the expression of ABL1 protein | CTD | PMID:16636310 | | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Gene Ontology Annotations
Molecular Pathway Annotations
Disease Annotations
Gene-Chemical Interaction Annotations
Gene Ontology Annotations
|
|
|
|
|
|
|
|
Molecular Pathway Annotations
|
|
| External Database Links | |
| KEGG Pathway | Axon guidance |
| Cell cycle | |
| Chronic myeloid leukemia | |
| ErbB signaling pathway | |
| Neurotrophin signaling pathway | |
| Pathogenic Escherichia coli infection | |
| Pathways in cancer | |
| Shigellosis | |
| Viral myocarditis | |
| Pathway Interaction Database | ATM pathway (PID:200072) |
| Lissencephaly gene (LIS1) in neuronal migration and development (PID:200132) | |
| Neurotrophic factor-mediated Trk receptor signaling (PID:200150) | |
| p53 pathway (PID:200206) | |
| p73 transcription factor network (PID:200017) | |
| PDGFR-beta signaling pathway (PID:200149) | |
| Posttranslational regulation of adherens junction stability and dissassembly (PID:200117) | |
| Regulation of retinoblastoma protein (PID:200223) | |
| Regulation of Telomerase (PID:200086) | |
| Validated transcriptional targets of TAp63 isoforms (PID:200203) | |
References - curated| 1. |
Collins SJ J Clin Invest. 1986 Nov;78(5):1392-6. |
| 2. |
GOA_HUMAN data from the GO Consortium |
| 3. |
Pipeline to import KEGG annotations from KEGG into RGD Pathway Ontology |
| 4. |
Pipeline to import Pathway Interaction Database annotations from NCI into RGD |
| 5. |
RGD automated import pipeline for gene-chemical interactions |
References - uncurated| PubMed | 10187839 |
| 10194451 | |
| 10212258 | |
| 10372803 | |
| 10391249 | |
| 10391250 | |
| 10391251 | |
| 10455176 | |
| 10488096 | |
| 10567556 | |
| 10571082 | |
| 10574931 | |
| 10608806 | |
| 10629029 | |
| 10635328 | |
| 10637231 | |
| 10679771 | |
| 10708759 | |
| 10713716 | |
| 10753870 | |
| 10777567 | |
| 10829062 | |
| 10837221 | |
| 10849448 | |
| 10892742 | |
| 10896159 | |
| 10945997 | |
| 10967110 | |
| 10970852 | |
| 10988075 | |
| 11021760 | |
| 11024037 | |
| 11071635 | |
| 11120811 | |
| 11121037 | |
| 11163214 | |
| 11266449 | |
| 11278340 | |
| 11279131 | |
| 11309382 | |
| 11350980 | |
| 11374898 | |
| 11375976 | |
| 11380621 | |
| 11390389 | |
| 11418237 | |
| 11420673 | |
| 11423618 | |
| 11431473 | |
| 11494128 | |
| 11494134 | |
| 11509666 | |
| 11593427 | |
| 11598012 | |
| 11708318 | |
| 11741929 | |
| 11780146 | |
| 11781820 | |
| 11790798 | |
| 11827972 | |
| 11840343 | |
| 11853795 | |
| 11891774 | |
| 11955625 | |
| 11956190 | |
| 11971963 | |
| 12021275 | |
| 12024016 | |
| 12107171 | |
| 12110584 | |
| 12130510 | |
| 12130516 | |
| 12138893 | |
| 12144533 | |
| 12149456 | |
| 12167702 | |
| 12198159 | |
| 12220663 | |
| 12374288 | |
| 12374739 | |
| 12379115 | |
| 12379650 | |
| 12384576 | |
| 12393636 | |
| 12408765 | |
| 12445832 | |
| 12468540 | |
| 12475393 | |
| 12477932 | |
| 12505259 | |
| 12522270 | |
| 12525554 | |
| 12543778 | |
| 12556557 | |
| 12560071 | |
| 12569093 | |
| 12573241 | |
| 12623848 | |
| 12626632 | |
| 12637538 | |
| 12650908 | |
| 12654250 | |
| 12663457 | |
| 12665579 | |
| 12672821 | |
| 12681507 | |
| 12764153 | |
| 12777393 | |
| 12777400 | |
| 12781448 | |
| 12810679 | |
| 1281542 | |
| 12824179 | |
| 12890867 | |
| 12893824 | |
| 12921956 | |
| 12928501 | |
| 12944467 | |
| 12950161 | |
| 12952226 | |
| 1379745 | |
| 1383690 | |
| 14527680 | |
| 14534537 | |
| 14581377 | |
| 14604282 | |
| 14657955 | |
| 14670960 | |
| 14679214 | |
| 14725908 | |
| 14745431 | |
| 14966468 | |
| 14993251 | |
| 1505033 | |
| 15143187 | |
| 15175272 | |
| 15361874 | |
| 1538749 | |
| 15481444 | |
| 15542838 | |
| 15556646 | |
| 15583852 | |
| 15588985 | |
| 15591787 | |
| 15608616 | |
| 15626746 | |
| 15657060 | |
| 15657136 | |
| 15661746 | |
| 15686624 | |
| 15696159 | |
| 15716990 | |
| 15723338 | |
| 15735728 | |
| 15735735 | |
| 15857938 | |
| 15886098 | |
| 15923648 | |
| 15937340 | |
| 15961388 | |
| 16014719 | |
| 16091742 | |
| 16135792 | |
| 16151465 | |
| 16158059 | |
| 16199863 | |
| 16205638 | |
| 16219545 | |
| 16273093 | |
| 16386788 | |
| 16410245 | |
| 16448696 | |
| 16543148 | |
| 16630659 | |
| 16636310 | |
| 16648821 | |
| 16678104 | |
| 16831423 | |
| 16867995 | |
| 16888623 | |
| 16899465 | |
| 16912036 | |
| 16955467 | |
| 16966279 | |
| 16998483 | |
| 17081983 | |
| 17101133 | |
| 17126298 | |
| 1712671 | |
| 17129785 | |
| 17160020 | |
| 17192257 | |
| 17196995 | |
| 17237826 | |
| 17252009 | |
| 17254966 | |
| 17268511 | |
| 17303698 | |
| 17339230 | |
| 17347407 | |
| 17349636 | |
| 17352427 | |
| 17366548 | |
| 17374743 | |
| 17409407 | |
| 17470729 | |
| 17470736 | |
| 17474147 | |
| 17486070 | |
| 17525531 | |
| 17541395 | |
| 17570524 | |
| 17579186 | |
| 17587335 | |
| 17597804 | |
| 17599053 | |
| 17604596 | |
| 17620332 | |
| 17623672 | |
| 17638918 | |
| 17695727 | |
| 17710227 | |
| 17761812 | |
| 17762503 | |
| 17764157 | |
| 17768119 | |
| 17804707 | |
| 17888034 | |
| 17889935 | |
| 17893873 | |
| 17925491 | |
| 17928051 | |
| 17943163 | |
| 17956664 | |
| 17972958 | |
| 18029348 | |
| 18036399 | |
| 18059481 | |
| 18067320 | |
| 18070606 | |
| 18082628 | |
| 18089786 | |
| 18095154 | |
| 18161990 | |
| 18180382 | |
| 18235045 | |
| 18262060 | |
| 18280240 | |
| 18287094 | |
| 18305217 | |
| 18305550 | |
| 18339898 | |
| 18362889 | |
| 18369471 | |
| 18391983 | |
| 18401414 | |
| 18406870 | |
| 18413724 | |
| 18427551 | |
| 18480060 | |
| 18480061 | |
| 18490454 | |
| 18538733 | |
| 18546844 | |
| 18559503 | |
| 1857987 | |
| 18603549 | |
| 18614052 | |
| 18619508 | |
| 1868241 | |
| 18687796 | |
| 18704194 | |
| 18765637 | |
| 18771174 | |
| 18775312 | |
| 18784740 | |
| 18794796 | |
| 18809728 | |
| 18827185 | |
| 18835194 | |
| 18936177 | |
| 18950845 | |
| 19001122 | |
| 19016792 | |
| 19020542 | |
| 19048492 | |
| 19052872 | |
| 19061839 | |
| 19075013 | |
| 19108887 | |
| 19124506 | |
| 19135771 | |
| 19156526 | |
| 19180499 | |
| 19203793 | |
| 19234221 | |
| 19260121 | |
| 19261608 | |
| 19275932 | |
| 19285032 | |
| 19295548 | |
| 19332026 | |
| 19357699 | |
| 19363261 | |
| 19369965 | |
| 19380743 | |
| 19383348 | |
| 19423701 | |
| 19427856 | |
| 19442657 | |
| 19531213 | |
| 19542604 | |
| 19557636 | |
| 19571320 | |
| 19608682 | |
| 19625707 | |
| 19643477 | |
| 19652056 | |
| 19657362 | |
| 19658100 | |
| 19660459 | |
| 19679652 | |
| 19697154 | |
| 19700222 | |
| 19724931 | |
| 19738611 | |
| 19768693 | |
| 19789182 | |
| 19818398 | |
| 19823681 | |
| 19829692 | |
| 19833721 | |
| 19876398 | |
| 19891780 | |
| 19897486 | |
| 19906645 | |
| 19914245 | |
| 19953087 | |
| 19954044 | |
| 19968720 | |
| 20007699 | |
| 20010464 | |
| 20038234 | |
| 20056178 | |
| 20073070 | |
| 20079431 | |
| 20082857 | |
| 20124512 | |
| 20152788 | |
| 20201926 | |
| 20234815 | |
| 20367437 | |
| 20425353 | |
| 20452982 | |
| 20453000 | |
| 20482842 | |
| 20512393 | |
| 20563669 | |
| 20581864 | |
| 20585028 | |
| 20585556 | |
| 20595523 | |
| 20598684 | |
| 20629032 | |
| 20633771 | |
| 20675402 | |
| 20697350 | |
| 20697894 | |
| 20717963 | |
| 20724541 | |
| 20798688 | |
| 20823226 | |
| 20861316 | |
| 20863169 | |
| 20937825 | |
| 20974687 | |
| 21045136 | |
| 21071472 | |
| 21072043 | |
| 21129254 | |
| 21156844 | |
| 21183952 | |
| 21203397 | |
| 21209200 | |
| 21220745 | |
| 21221851 | |
| 21239056 | |
| 21248063 | |
| 21266020 | |
| 21320496 | |
| 21321929 | |
| 21368377 | |
| 21388681 | |
| 21435002 | |
| 21454413 | |
| 21455220 | |
| 21461967 | |
| 21480391 | |
| 21504383 | |
| 21527514 | |
| 21591355 | |
| 2163052 | |
| 21641753 | |
| 21674858 | |
| 21693657 | |
| 21694468 | |
| 21715626 | |
| 21764785 | |
| 21781306 | |
| 2183353 | |
| 21888027 | |
| 21892207 | |
| 21900237 | |
| 21903771 | |
| 2193202 | |
| 21935931 | |
| 21960589 | |
| 21961412 | |
| 21998569 | |
| 22001646 | |
| 22014333 | |
| 22054731 | |
| 22089930 | |
| 22140458 | |
| 22184410 | |
| 22231445 | |
| 22233112 | |
| 22238610 | |
| 22252550 | |
| 22311485 | |
| 22314255 | |
| 22327125 | |
| 22327338 | |
| 22334513 | |
| 22378042 | |
| 22380496 | |
| 22447844 | |
| 22454521 | |
| 22462553 | |
| 22471662 | |
| 22526369 | |
| 22590567 | |
| 22591684 | |
| 22593461 | |
| 22632162 | |
| 22649097 | |
| 22665066 | |
| 22693568 | |
| 22733220 | |
| 22783572 | |
| 22787435 | |
| 22847163 | |
| 22879933 | |
| 22939624 | |
| 22939629 | |
| 22957062 | |
| 22974441 | |
| 22988030 | |
| 23044928 | |
| 23053188 | |
| 23062378 | |
| 23087049 | |
| 23117882 | |
| 23124138 | |
| 23171811 | |
| 23223358 | |
| 23287430 | |
| 23303187 | |
| 23316053 | |
| 23319661 | |
| 23325923 | |
| 2542016 | |
| 2678002 | |
| 2687768 | |
| 2825022 | |
| 2989692 | |
| 2989703 | |
| 3021337 | |
| 3023859 | |
| 3313010 | |
| 3471171 | |
| 4062888 | |
| 6191223 | |
| 6281890 | |
| 6302194 | |
| 6316147 | |
| 6319012 | |
| 6323103 | |
| 7493940 | |
| 7512963 | |
| 7533294 | |
| 7545908 | |
| 7565761 | |
| 7590236 | |
| 7665185 | |
| 7760813 | |
| 7780740 | |
| 7828850 | |
| 7892170 | |
| 7926767 | |
| 7968380 | |
| 8112292 | |
| 8114715 | |
| 8194526 | |
| 8242749 | |
| 8294442 | |
| 8438166 | |
| 8453102 | |
| 8524328 | |
| 8590002 | |
| 8626527 | |
| 8626543 | |
| 8629002 | |
| 8630736 | |
| 8668148 | |
| 8668151 | |
| 8692915 | |
| 8810278 | |
| 8875975 | |
| 8879209 | |
| 8943360 | |
| 8978305 | |
| 9006901 | |
| 9008161 | |
| 9010225 | |
| 9037071 | |
| 9067577 | |
| 9071815 | |
| 9111318 | |
| 9144171 | |
| 9168116 | |
| 9168117 | |
| 9174058 | |
| 9195915 | |
| 9211900 | |
| 9312071 | |
| 9315092 | |
| 9334312 | |
| 9356459 | |
| 9407116 | |
| 9461559 | |
| 9480911 | |
| 9516488 | |
| 9583676 | |
| 9593709 | |
| 9603926 | |
| 9632734 | |
| 9632788 | |
| 9642287 | |
| 9698566 | |
| 9710592 | |
| 9747873 | |
| 9774693 | |
| 9798959 | |
| 9820532 | |
| 9872323 | |
| 9949177 |
RGD Disease Portals| ABL1 has been annotated in the following RGD Disease Portals. |
|||||
![]() |
| ||||
![]() |
| ||||
![]() |
| ||||
![]() |
| ||||
![]() |
| ||||
![]() |
| ||||
![]() |
| ||||
Comparative Map Data| ABL1 (Homo sapiens) |
|
|||||||||||||||||||||||||||||||||||
| Abl1 (Mus musculus) |
|
|||||||||||||||||||||||||||||||||||
| Abl1 (Rattus norvegicus) |
|
Position Markers| RH80013 |
|
|||||||||||||||||||||||||||||||||||||||||||||
| RH103512 |
|
|||||||||||||||||||||||||||||||||||||||||||||
| GDB:178527 |
|
|||||||||||||||||||||||||||||||||||||||||||||
| GDB:178528 |
|
|||||||||||||||||||||||||||||||||||||||||||||
| GDB:181505 |
|
|||||||||||||||||||||||||||||||||||||||||||||
| PMC20354P4 |
|
|||||||||||||||||||||||||||||||||||||||||||||
| A009E06 |
|
|||||||||||||||||||||||||||||||||||||||||||||
| ABL1_685.2 |
|
|||||||||||||||||||||||||||||||||||||||||||||
| G29321 |
|
|||||||||||||||||||||||||||||||||||||||||||||
| RH69429 |
|
|||||||||||||||||||||||||||||||||||||||||||||
| WI-12399 |
|
|||||||||||||||||||||||||||||||||||||||||||||
| BCR |
|
|||||||||||||||||||||||||||||||||||||||||||||
| G32466 |
|
|||||||||||||||||||||||||||||||||||||||||||||
| GDB:177067 | No map positions available. |
QTLs in Region (Human Genome Assembly GRCh37)| The following QTLs overlap with this region. | ![]() | Full Report | ![]() | CSV | ![]() | TAB | ![]() | Printer | ![]() | Gviewer |
Nucleotide Sequences| Nucleotide RefSeqs | NG_012034 | (Get FASTA) | Search GEO for Microarray Profiles |
| NM_005157 | (Get FASTA) | Search GEO for Microarray Profiles | |
| NM_007313 | (Get FASTA) | Search GEO for Microarray Profiles | |
| GenBank Nucleotide | AA524892 | (Get FASTA) | Search GEO for Microarray Profiles |
| AB209456 | (Get FASTA) | Search GEO for Microarray Profiles | |
| AB209642 | (Get FASTA) | Search GEO for Microarray Profiles | |
| ABBA01012061 | (Get FASTA) | Search GEO for Microarray Profiles | |
| ABBA01012062 | (Get FASTA) | Search GEO for Microarray Profiles | |
| ABBA01012063 | (Get FASTA) | Search GEO for Microarray Profiles | |
| ABBA01012064 | (Get FASTA) | Search GEO for Microarray Profiles | |
| ABBA01012065 | (Get FASTA) | Search GEO for Microarray Profiles | |
| ABBA01012066 | (Get FASTA) | Search GEO for Microarray Profiles | |
| ABBA01012067 | (Get FASTA) | Search GEO for Microarray Profiles | |
| AK294983 | (Get FASTA) | Search GEO for Microarray Profiles | |
| AL161733 | (Get FASTA) | Search GEO for Microarray Profiles | |
| AL359092 | (Get FASTA) | Search GEO for Microarray Profiles | |
| AL707819 | (Get FASTA) | Search GEO for Microarray Profiles | |
| AMYH01021772 | (Get FASTA) | Search GEO for Microarray Profiles | |
| AMYH01021773 | (Get FASTA) | Search GEO for Microarray Profiles | |
| AMYH01021774 | (Get FASTA) | Search GEO for Microarray Profiles | |
| BC107069 | (Get FASTA) | Search GEO for Microarray Profiles | |
| BC107070 | (Get FASTA) | Search GEO for Microarray Profiles | |
| BC117451 | (Get FASTA) | Search GEO for Microarray Profiles | |
| CA335983 | (Get FASTA) | Search GEO for Microarray Profiles | |
| CH471090 | (Get FASTA) | Search GEO for Microarray Profiles | |
| DQ145721 | (Get FASTA) | Search GEO for Microarray Profiles | |
| K00009 | (Get FASTA) | Search GEO for Microarray Profiles | |
| M14752 | (Get FASTA) | Search GEO for Microarray Profiles | |
| M14753 | (Get FASTA) | Search GEO for Microarray Profiles | |
| M14754 | (Get FASTA) | Search GEO for Microarray Profiles | |
| M25946 | (Get FASTA) | Search GEO for Microarray Profiles | |
| M25949 | (Get FASTA) | Search GEO for Microarray Profiles | |
| M30833 | (Get FASTA) | Search GEO for Microarray Profiles | |
| S69223 | (Get FASTA) | Search GEO for Microarray Profiles | |
| U07563 | (Get FASTA) | Search GEO for Microarray Profiles | |
| X16416 | (Get FASTA) | Search GEO for Microarray Profiles |
| RefSeq Acc Id: | NM_007313 | |||||||||||||||||||||||||
| RefSeq Status: | REVIEWED | |||||||||||||||||||||||||
| Type: | CODING | |||||||||||||||||||||||||
| Protein Acc Id: | NP_009297 | |||||||||||||||||||||||||
| Peptide Label: | isoform b | |||||||||||||||||||||||||
| Position: |
|
| RefSeq Acc Id: | NM_005157 | |||||||||||||||||||||||||
| RefSeq Status: | REVIEWED | |||||||||||||||||||||||||
| Type: | CODING | |||||||||||||||||||||||||
| Protein Acc Id: | NP_005148 | |||||||||||||||||||||||||
| Peptide Label: | isoform a | |||||||||||||||||||||||||
| Position: |
|
Protein Sequences| Protein RefSeqs | NP_005148 | (Get FASTA) |
| NP_009297 | (Get FASTA) | |
| GenBank Protein | AAA35593 | (Get FASTA) |
| AAA35697 | (Get FASTA) | |
| AAA51561 | (Get FASTA) | |
| AAA51562 | (Get FASTA) | |
| AAA51563 | (Get FASTA) | |
| AAA51895 | (Get FASTA) | |
| AAA88011 | (Get FASTA) | |
| AAA88012 | (Get FASTA) | |
| AAB60393 | (Get FASTA) | |
| AAB60394 | (Get FASTA) | |
| AAD14034 | (Get FASTA) | |
| AAI07070 | (Get FASTA) | |
| AAI07071 | (Get FASTA) | |
| AAI17452 | (Get FASTA) | |
| AAZ38718 | (Get FASTA) | |
| BAD92693 | (Get FASTA) | |
| BAD92879 | (Get FASTA) | |
| BAG58052 | (Get FASTA) | |
| CAA34438 | (Get FASTA) | |
| EAW87947 | (Get FASTA) | |
| EAW87948 | (Get FASTA) | |
| EAW87949 | (Get FASTA) | |
| P00519 | (Get FASTA) |
Promoters| RGD ID: | 6863014 | ||||||||||
| Promoter ID: | EPDNEW_H4672 | ||||||||||
| Type: | initiation region | ||||||||||
| Name: | ZNF385D_1 | ||||||||||
| Description: | zinc finger protein 385D | ||||||||||
| SO ACC ID: | SO:0000170 | ||||||||||
| Source: | EPDNEW (Eukaryotic Promoter Database, http://epd.vital-it.ch/) | ||||||||||
| Position: |
|
| RGD ID: | 6807200 | ||||||||||
| Promoter ID: | HG_KWN:65322 | ||||||||||
| Type: | CpG-Island | ||||||||||
| SO ACC ID: | SO:0000170 | ||||||||||
| Source: | MPROMDB | ||||||||||
| Tissues & Cell Lines: | CD4+TCell, CD4+TCell_12Hour, HeLa_S3, Jurkat, K562, Lymphoblastoid, NB4 | ||||||||||
| Transcripts: | ENST00000393293, NM_007313, OTTHUMT00000054686 | ||||||||||
| Position: |
|
| RGD ID: | 6850274 | ||||||||||
| Promoter ID: | EP26030 | ||||||||||
| Type: | single initiation site | ||||||||||
| Name: | HS_ABL1_1 | ||||||||||
| Description: | Cellular-Abelson murine leukemia virus oncogene 7kb. | ||||||||||
| SO ACC ID: | SO:0000170 | ||||||||||
| Source: | EPD (Eukaryotic Promoter Database, http://epd.vital-it.ch/) | ||||||||||
| Alternative Promoters: | alternative promoter #1 of 3; 5' exon 1; site 1.; see also EP26031 EP26032 | ||||||||||
| Experiment Methods: | Nuclease protection with homologous sequence ladder | ||||||||||
| Regulation: | most tissues; (induced by or strongly expressed in) spleen, (induced by or strongly expressed in) thymus, (induced by or strongly expressed in) testis | ||||||||||
| Position: |
|
| RGD ID: | 6850276 | ||||||||||
| Promoter ID: | EP26031 | ||||||||||
| Type: | multiple initiation site | ||||||||||
| Name: | HS_ABL1_2 | ||||||||||
| Description: | Cellular-Abelson murine leukemia virus oncogene 7kb. | ||||||||||
| SO ACC ID: | SO:0000170 | ||||||||||
| Source: | EPD (Eukaryotic Promoter Database, http://epd.vital-it.ch/) | ||||||||||
| Alternative Promoters: | alternative promoter #2 of 3; 5' exon 1; site 2.; see also EP26030 EP26032 | ||||||||||
| Experiment Methods: | Nuclease protection with homologous sequence ladder | ||||||||||
| Regulation: | most tissues; (induced by or strongly expressed in) spleen, (induced by or strongly expressed in) thymus, (induced by or strongly expressed in) testis | ||||||||||
| Position: |
|
| RGD ID: | 6807199 | ||||||||||
| Promoter ID: | HG_KWN:65323 | ||||||||||
| Type: | CpG-Island | ||||||||||
| SO ACC ID: | SO:0000170 | ||||||||||
| Source: | MPROMDB | ||||||||||
| Tissues & Cell Lines: | CD4+TCell, CD4+TCell_2Hour, HeLa_S3, Jurkat, K562, Lymphoblastoid, NB4 | ||||||||||
| Transcripts: | OTTHUMT00000054684 | ||||||||||
| Position: |
|
| RGD ID: | 6850280 | ||||||||||
| Promoter ID: | EP26032 | ||||||||||
| Type: | initiation region | ||||||||||
| Name: | HS_ABL1_3 | ||||||||||
| Description: | Cellular-Abelson murine leukemia virus oncogene 6kb. | ||||||||||
| SO ACC ID: | SO:0000170 | ||||||||||
| Source: | EPD (Eukaryotic Promoter Database, http://epd.vital-it.ch/) | ||||||||||
| Alternative Promoters: | alternative promoter #3 of 3; 5' exon 2; site 1.; see also EP26030 EP26031 | ||||||||||
| Experiment Methods: | Nuclease protection with homologous sequence ladder | ||||||||||
| Regulation: | most tissues; (induced by or strongly expressed in) spleen, (induced by or strongly expressed in) thymus, (induced by or strongly expressed in) testis | ||||||||||
| Position: |
|
External Database Links| Database | Acc Id | Source(s) |
| COSMIC | ABL1 | COSMIC |
| Ensembl Genes | ENSG00000097007 | ENTREZGENE |
| Ensembl Protein | ENSP00000323315 | ENTREZGENE |
| Ensembl Transcript | ENST00000318560 | ENTREZGENE |
| Entrez Gene | 25 | ENTREZGENE |
| Gene3D-CATH | SH2 | UniProtKB/Swiss-Prot |
| Germonline | ENSG00000097007 | |
| HGNC ID | 76 | ENTREZGENE |
| HomoloGene Group ID | 3783 | ENTREZGENE |
| HPRD ID | 01809 | ENTREZGENE |
| InterPro | F-actin_binding | UniProtKB/Swiss-Prot |
| Kinase-like_dom | UniProtKB/Swiss-Prot | |
| Prot_kinase_cat_dom | UniProtKB/Swiss-Prot | |
| Protein_kinase_ATP_BS | UniProtKB/Swiss-Prot | |
| Ser-Thr/Tyr_kinase | UniProtKB/Swiss-Prot | |
| SH2 | UniProtKB/Swiss-Prot | |
| SH3_domain | UniProtKB/Swiss-Prot | |
| Tyr_kinase_AS | UniProtKB/Swiss-Prot | |
| Tyr_kinase_cat_dom | UniProtKB/Swiss-Prot | |
| KEGG Report | hsa:25 | ENTREZGENE, UniProtKB/Swiss-Prot |
| OMIM | 189980 | OMIM |
| Pfam | F_actin_bind | UniProtKB/Swiss-Prot |
| Pkinase_Tyr | UniProtKB/Swiss-Prot | |
| SH2 | UniProtKB/Swiss-Prot | |
| SH3_1 | UniProtKB/Swiss-Prot | |
| PharmGKB | ABL1 | RGD, PharmGKB |
| PRINTS | SH2DOMAIN | UniProtKB/Swiss-Prot |
| TYRKINASE | UniProtKB/Swiss-Prot | |
| PROSITE | PROTEIN_KINASE_ATP | UniProtKB/Swiss-Prot |
| PROTEIN_KINASE_DOM | UniProtKB/Swiss-Prot | |
| PROTEIN_KINASE_TYR | UniProtKB/Swiss-Prot | |
| SH2 | UniProtKB/Swiss-Prot | |
| SH3 | UniProtKB/Swiss-Prot | |
| SMART | FABD | UniProtKB/Swiss-Prot |
| SH2 | UniProtKB/Swiss-Prot | |
| SH3 | UniProtKB/Swiss-Prot | |
| TyrKc | UniProtKB/Swiss-Prot | |
| Superfamily-SCOP | Kinase_like | UniProtKB/Swiss-Prot |
| SH3 | UniProtKB/Swiss-Prot | |
| UniGene | Hs.431048 | ENTREZGENE |
| UniProt | ABL1_HUMAN | UniProtKB/Swiss-Prot |
| Q13688_HUMAN | UniProtKB/TrEMBL | |
| Q59FK4_HUMAN | UniProtKB/TrEMBL |
Nomenclature History| Date | Current Symbol | Current Name | Previous Symbol | Previous Name | Description | Reference | Status |
|---|---|---|---|---|---|---|---|
| 2012-03-01 | ABL1 | c-abl oncogene 1, non-receptor tyrosine kinase | ABL1 | c-abl oncogene 1, non-receptor tyrosine kinase | Symbol and/or name change | 39860 | APPROVED |
| 2011-08-16 | ABL1 | c-abl oncogene 1, non-receptor tyrosine kinase | ABL1 | c-abl oncogene 1, non-receptor tyrosine kinase | Symbol and/or name change | 39860 | APPROVED |
| 2011-07-27 | ABL1 | c-abl oncogene 1, non-receptor tyrosine kinase | ABL1 | c-abl oncogene 1, receptor tyrosine kinase | Symbol and/or name change | 39860 | APPROVED |
| More on ABL1 | |||
![]() |
Entrez Gene | ||
![]() |
Ensembl Gene | ||
|
|
||
![]() |
HGNC Report | ||
![]() |
NCBI Map Viewer | ||
![]() |
Vista | ||
![]() |
Vista + UCSC | ||
| RGD Object Information | |
| RGD ID: | 1342972 |
| Created: | 2005-03-08 |
| Species: | Homo sapiens |
| Last Modified: | 2013-05-28 |
| Status: | ACTIVE |
© Bioinformatics Program, HMGC at the Medical College of Wisconsin
RGD is funded by grant HL64541 from the National Heart, Lung, and Blood Institute on behalf of the NIH.




